These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9252189)

  • 1. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors.
    Maldonado R; Saiardi A; Valverde O; Samad TA; Roques BP; Borrelli E
    Nature; 1997 Aug; 388(6642):586-9. PubMed ID: 9252189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inputs from the basolateral amygdala to the nucleus accumbens shell control opiate reward magnitude via differential dopamine D1 or D2 receptor transmission.
    Lintas A; Chi N; Lauzon NM; Bishop SF; Sun N; Tan H; Laviolette SR
    Eur J Neurosci; 2012 Jan; 35(2):279-90. PubMed ID: 22236063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rewarding effects of opiates are absent in mice lacking the receptor for substance P.
    Murtra P; Sheasby AM; Hunt SP; De Felipe C
    Nature; 2000 May; 405(6783):180-3. PubMed ID: 10821273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrahippocampal administration of D2 but not D1 dopamine receptor antagonist suppresses the expression of conditioned place preference induced by morphine in the ventral tegmental area.
    Haghparast A; Esmaeili MH; Taslimi Z; Kermani M; Yazdi-Ravandi S; Alizadeh AM
    Neurosci Lett; 2013 Apr; 541():138-43. PubMed ID: 23499959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of D1/D2 dopamine receptors in the CA1 region of the rat hippocampus in the rewarding effects of morphine administered into the ventral tegmental area.
    Esmaeili MH; Kermani M; Parvishan A; Haghparast A
    Behav Brain Res; 2012 May; 231(1):111-5. PubMed ID: 22426507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D2L receptor knockout mice display deficits in positive and negative reinforcing properties of morphine and in avoidance learning.
    Smith JW; Fetsko LA; Xu R; Wang Y
    Neuroscience; 2002; 113(4):755-65. PubMed ID: 12182883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of the dopamine D2/D3 receptor antagonist sulpiride on self-administration of morphine into the ventral tegmental area or the nucleus accumbens.
    David V; Durkin TP; Cazala P
    Psychopharmacology (Berl); 2002 Mar; 160(3):307-17. PubMed ID: 11889500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corydaline and l-tetrahydropalmatine attenuate morphine-induced conditioned place preference and the changes in dopamine D
    Jiang WN; Jing X; Li M; Deng H; Jiang T; Xiong KZ; Chen Y; Wang XF; Wang QJ
    Eur J Pharmacol; 2020 Oct; 884():173397. PubMed ID: 32717192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A ghrelin receptor (GHS-R1A) antagonist attenuates the rewarding properties of morphine and increases opioid peptide levels in reward areas in mice.
    Engel JA; Nylander I; Jerlhag E
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2364-71. PubMed ID: 26508707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain stimulation and morphine reward deficits in dopamine D2 receptor-deficient mice.
    Elmer GI; Pieper JO; Levy J; Rubinstein M; Low MJ; Grandy DK; Wise RA
    Psychopharmacology (Berl); 2005 Oct; 182(1):33-44. PubMed ID: 16136297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opiate-like effects of sugar on gene expression in reward areas of the rat brain.
    Spangler R; Wittkowski KM; Goddard NL; Avena NM; Hoebel BG; Leibowitz SF
    Brain Res Mol Brain Res; 2004 May; 124(2):134-42. PubMed ID: 15135221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxone's suppression of spontaneous and food-conditioned locomotor activity is diminished in mice lacking either the dopamine D(2) receptor or enkephalin.
    Hayward MD; Low MJ
    Brain Res Mol Brain Res; 2005 Oct; 140(1-2):91-8. PubMed ID: 16125819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the highly selective and nonpeptide delta opioid receptor agonist TAN-67 on the morphine-induced place preference in mice.
    Suzuki T; Tsuji M; Mori T; Misawa M; Endoh T; Nagase H
    J Pharmacol Exp Ther; 1996 Oct; 279(1):177-85. PubMed ID: 8858991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute food deprivation reverses morphine-induced locomotion deficits in M5 muscarinic receptor knockout mice.
    Steidl S; Lee E; Wasserman D; Yeomans JS
    Behav Brain Res; 2013 Sep; 252():176-9. PubMed ID: 23742799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine alters the locomotor responses to a D2/D3 dopamine receptor agonist differentially in adolescent and adult mice.
    Hofford RS; Wellman PJ; Eitan S
    J Psychopharmacol; 2012 Oct; 26(10):1355-65. PubMed ID: 22522973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of intravenous morphine to serve as an effective instrumental reinforcer in dopamine D2 receptor knock-out mice.
    Elmer GI; Pieper JO; Rubinstein M; Low MJ; Grandy DK; Wise RA
    J Neurosci; 2002 May; 22(10):RC224. PubMed ID: 12006606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Exposure to bisphenol-A affects the rewarding system in mice].
    Suzuki T; Mizuo K; Miyagawa K; Narita M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Jun; 25(3):125-8. PubMed ID: 16045194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reinforcing effects of chronic D-amphetamine and morphine are impaired in a line of memory-deficient mice overexpressing calcineurin.
    Biala G; Betancur C; Mansuy IM; Giros B
    Eur J Neurosci; 2005 Jun; 21(11):3089-96. PubMed ID: 15978018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral activation induced by D(2)-like receptor stimulation during opiate withdrawal.
    Druhan JP; Walters CL; Aston-Jones G
    J Pharmacol Exp Ther; 2000 Aug; 294(2):531-8. PubMed ID: 10900229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.